A Combinatorial CRISPR-Cas9 Screen Identifies Ifenprodil as an Adjunct to Sorafenib for Liver Cancer Treatment.
Cancer Res. 2021 Dec 15;81(24):6219-6232. doi: 10.1158/0008-5472.CAN-21-1017. Epub 2021 Oct 19.
Cancer Res. 2021.
PMID: 34666996